Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Clinical Features and Outcomes of Localized Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Dual-Center Retrospective Observational Study with a Long-Term Follow-up

Blood (2024) 144 (Supplement 1): 3026.

https://doi.org/10.1182/blood-2024-193605

Published: 2024

Journal Articles

Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)

Blood (2022) 140 (Supplement 1): 11890–11892.

https://doi.org/10.1182/blood-2022-164977

Published: 2022

Journal Articles

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Blood (2021) 138 (Supplement 1): 2451.

https://doi.org/10.1182/blood-2021-146340

Published: 2021

Journal Articles

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Tomotaka Suzuki, MD, Suguru Fukuhara, MD, Junko Nomoto, PhD, Satoshi Yamashita, PhD, Akiko Miyagi Maeshima, MD PhD, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD PhD, Shinichi Makita, MD, PhD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Dai Maruyama, MD PhD, Hirokazu Taniguchi, MD, PhD, Toshikazu Ushijima, MD PhD, Koji Izutsu, MDPhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MDDSc

Blood (2018) 132 (Supplement 1): 1571.

https://doi.org/10.1182/blood-2018-99-111262

Published: 2018

Journal Articles

Impact of the Double Expression of MYC and BCL2 on Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma Following R-CHOP Chemoimmunotherapy

Tomotaka Suzuki, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Kinuko Tajima, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD, PhD, Shinichi Makita, MD, PhD, Suguru Fukuhara, MD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Hirokazu Taniguchi, MD, Yukio Kobayashi, MD PhD, Koji Izutsu, MD, PhD, Kensei Tobinai, MD PhD

Blood (2017) 130 (Supplement 1): 2846.

https://doi.org/10.1182/blood.V130.Suppl_1.2846.2846

Published: 2017

Journal Articles

Comparison of Genetic Profiling of Primary Central Nervous System (CNS) Lymphoma before and after Extra-CNS Relapse

Kosuke Toyoda, MD, Junko Nomoto, MD PhD, Yasuji Miyakita, MD, Yoshitaka Narita, MD PhD, Akiko Miyagi Maeshima, MD PhD, Nobuhiko Yamauchi, MD, Suguru Fukuhara, MD, Wataru Munakata, MD PhD, Dai Maruyama, MD PhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MD PhD

Blood (2017) 130 (Supplement 1): 5135.

https://doi.org/10.1182/blood.V130.Suppl_1.5135.5135

Published: 2017

Journal Articles

Role of FDG-PET/CT in the Staging of Patients with Follicular Lymphoma

Sayako Yuda, MD, Dai Maruyama, MD PhD, Hiroaki Kurihara, MD, Akiko Miyagi Maeshima, MD, Kosuke Toyoda, MD, Yamauchi Nobuhiko, MD, Shin-ichi Makita, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Yukio Kobayashi, MD PhD, Hirokazu Taniguchi, MD, Kensei Tobinai, MD PhD

Blood (2015) 126 (23): 5010.

https://doi.org/10.1182/blood.V126.23.5010.5010

Published: 2015

Journal Articles

Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma

Hideaki Saito, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Ken-ichi Miyamoto, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Tatsuya Suzuki, MD PhD, Yukio Kobayashi, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 3066.

https://doi.org/10.1182/blood.V124.21.3066.3066

Published: 2014

Journal Articles

The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy

Akihisa Kawajiri, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Ken-ichi Miyamoto, MD, Suguru Fukuhara, MD, Tatsuya Suzuki, MD PhD, Wataru Munakata, MD, Yukio Kobayashi, Kinuko Tajima, Jun Itami, MD PhD, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 1761.

https://doi.org/10.1182/blood.V124.21.1761.1761

Published: 2014

Journal Articles

Influence of the Watch and Wait Strategy on the Clinical Outcome in Patients with Follicular Lymphoma in the Rituximab Era

Sayako Yuda, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Miyamoto Ken-ichi, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Tatsuya Suzuki, MD PhD, Yukio Kobayashi, MD PhD, Kinuko Tajima, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 4475.

https://doi.org/10.1182/blood.V124.21.4475.4475

Published: 2014

Journal Articles

Clinicopathological Prognostic Indicators Of 24 Patients With B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma

Ken-ichi Miyamoto, MD, Akiko Miyagi Maeshima, MD, PhD, Hirokazu Taniguchi, MD, PhD, Junko Nomoto, PhD, Hideaki Kitahara, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Dai Maruyama, MD, PhD, Sung-Won Kim, MD, PhD, Yukio Kobayashi, MD, PhD, Kensei Tobinai, MD, PhD

Blood (2013) 122 (21): 5085.

https://doi.org/10.1182/blood.V122.21.5085.5085

Published: 2013

Journal Articles

Clinicopathologic Analysis of Follicular Lymphoma (FL) Patients with Coexisting Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Rituximab-Containing Chemotherapy

Suguru Fukuhara, MD, Dai Maruyama, MD, PhD, Ken-ichi Miyamoto, MD, Sung-Won Kim, MD, PhD, Takashi Watanabe, MD, PhD, Yukio Kobayashi, MD, PhD, Hirokazu Taniguchi, MD, PhD, Akiko Miyagi Maeshima, MD, PhD, Kensei Tobinai, MD, PhD

Blood (2012) 120 (21): 3693.

https://doi.org/10.1182/blood.V120.21.3693.3693

Published: 2012

NARROW

Clinical Features and Outcomes of Localized Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Dual-Center Retrospective Observational Study with a Long-Term Follow-up

Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Impact of the Double Expression of MYC and BCL2 on Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma Following R-CHOP Chemoimmunotherapy

Comparison of Genetic Profiling of Primary Central Nervous System (CNS) Lymphoma before and after Extra-CNS Relapse

Role of FDG-PET/CT in the Staging of Patients with Follicular Lymphoma

Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma

The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy

Influence of the Watch and Wait Strategy on the Clinical Outcome in Patients with Follicular Lymphoma in the Rituximab Era

Clinicopathological Prognostic Indicators Of 24 Patients With B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma

Clinicopathologic Analysis of Follicular Lymphoma (FL) Patients with Coexisting Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Rituximab-Containing Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only